Selenium oral - Institute for Cancer Prevention/Integrated BioPharmaAlternative Names: Phytosel
Latest Information Update: 21 Jul 2010
At a glance
- Originator INB:Biotechnologies; Institute for Cancer Prevention; Integrated BioPharma
- Developer iBio Inc; Institute for Cancer Prevention; Integrated BioPharma
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chemoprotection
Most Recent Events
- 10 Jul 2006 Phase-I clinical trials in Chemoprotection in USA (PO)